Literature DB >> 2530453

A glycophospholipid anchor is required for Qa-2-mediated T cell activation.

P J Robinson1, M Millrain, J Antoniou, E Simpson, A L Mellor.   

Abstract

A number of lymphocyte surface proteins are anchored in the cell membrane by glycophosphatidyl inositol (known as GPI) linkages instead of hydrophobic protein domains. Treatment of mouse T lymphocytes with antibodies specific for two such proteins, Thy-1 and Ly-6, are known to induce proliferation. We have found that antibodies specific for Qa-2, a GPI-anchored class I histocompatibility antigen, can also activate mouse T cells. To determine whether the GPI-anchor is important for this pathway of cell activation, we produced transgenic mice expressing either normal GPI-anchored Qa-2, or Qa-2 molecules with a membrane-spanning protein domain derived from H-2. Our studies show that only lymphocytes from transgenic mice carrying GPI-anchored forms of Qa-2 can be activated in vitro by Qa-2-specific antibodies. We also show that transgenic mouse T cells expressing a GPI-anchored form of H-2Db can be activated by anti-H-2Db antibodies. These results strongly indicate that the GPI-anchor is critical for this pathway of T cell activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530453     DOI: 10.1038/342085a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

1.  Chemical synthesis and functionalization of clickable glycosylphosphatidylinositol anchors.

Authors:  Benjamin M Swarts; Zhongwu Guo
Journal:  Chem Sci       Date:  2011       Impact factor: 9.825

2.  Activation of T lymphocytes by cross-linking of glycophospholipid-anchored Thy-1 mobilizes separate pools of intracellular second messengers to those induced by the antigen-receptor/CD3 complex.

Authors:  E Barboni; A M Gormley; F B Pliego Rivero; M Vidal; R J Morris
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

3.  HLA-G is found in lipid rafts and can act as a signaling molecule.

Authors:  Martina Comiskey; Kenneth E Domino; Carol M Warner
Journal:  Hum Immunol       Date:  2006-11-03       Impact factor: 2.850

4.  Synthetic Studies of Glycosylphosphatidylinositol (GPI) Anchors and GPI-Anchored Peptides, Glycopeptides, and Proteins.

Authors:  Zhongwu Guo
Journal:  Curr Org Synth       Date:  2013-06-01       Impact factor: 1.975

Review 5.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 6.  Chemical synthesis of glycosylphosphatidylinositol anchors.

Authors:  Benjamin M Swarts; Zhongwu Guo
Journal:  Adv Carbohydr Chem Biochem       Date:  2012       Impact factor: 12.200

7.  Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties.

Authors:  S D Tachado; P Gerold; R Schwarz; S Novakovic; M McConville; L Schofield
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

8.  Promotion of cytotoxic T-cell generation in mixed leukocyte culture by phosphatidylinositol-specific phospholipase C from Bacillus thuringiensis.

Authors:  S M Rahman; M Y Pu; H Yi; K Ohkusu; M Kato; K Isobe; R Taguchi; H Ikezawa; I Nakashima
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  The ethanolamine requirement of keratinocytes for growth is not due to defective synthesis of ethanolamine phosphoacylglycerols by the decarboxylation pathway.

Authors:  G Arthur; X Lu
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

10.  Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin.

Authors:  J D Lee; V Kravchenko; T N Kirkland; J Han; N Mackman; A Moriarty; D Leturcq; P S Tobias; R J Ulevitch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.